Table 1.
I | II | III | |
---|---|---|---|
Number | 3 | 38 | 20 |
Age in years, range | 13–15 | 8–18 | 8–17 |
Male (n) | 1 | 19 | 10 |
Female (n) | 2 | 19 | 10 |
Diagnosis | |||
ulcerative colitis | 16 | 9 | |
Crohn’s disease | 3 | 20 | 11 |
IBD unclassified | 2 | ||
Age at diagnosis (years) | 7–11 | 8–18 | 5–16 |
Treatment at time of analysis | |||
no | 38 | 3 | |
azathioprine | 2 | 7 | |
mesalazine | 2 | ||
infliximab | 6 | ||
methotrexate | 1 | 1 | |
prednisolone | 4 | ||
adalimumab | 1 | 3 | |
6-mercaptopurine | 1 | ||
Treatment history | |||
azathioprine | 3 | ||
mesalazine | 2 | ||
infliximab | 3 | ||
methotrexate | 1 | ||
prednisolone | 3 | ||
adalimumab | 3 | ||
6-mercaptopurine | |||
Surgery | 3 | 10 |